An interventional study of Flapless transcrestal sinus lift approach with TPRF and Flapless transcrestal sinus lift approach with PRF in Sinus Floor Elevation, sponsored by Hams Hamed Abdelrahman. Completed at 1 site in Egypt. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-02-21.
Sponsored by Hams Hamed Abdelrahman · Not applicable, Interventional, and Treatment
Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence flapless transcrestal sinus floor elevation is minimally invasive technique which is used in moderately defected maxilla.
Aim of the study: to evaluate both clinical and radiographic outcomes in sinus floor elevation following dental implant placement using flapless transcrestal sinus lift approach with Titanium platelet rich fibrin (TPRF) as a sole sinus graft material compared to Platelet rich fibrin (PRF).
Hams Hamed Abdelrahman is the lead sponsor of 107 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Flapless transcrestal sinus lift approach with TPRF
Other: Flapless transcrestal sinus lift approach with PRF
Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the TPRF as a sole grafting material.
Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the PRF as a sole grafting material.
Change in bone density
Cuts of CBCT (cross sectional, axial and sagittal view), bone density, will be analyzed using On-demand software. The radiographic evaluation will be based on radiological parameters, using reference points and lines at T0 and T1.
Time frame: Baseline and 6 months
Change in implant stability
Secondary implant stability will be measured 6 months post-operatively using Osstell device.
Time frame: Baseline and 6 months
change in pain scores
Pain (by Visual Analogous Scale) ranges from 0 to 10 0 - No pain. 2 to 4 - Mild pain. 5 to 7 - Moderate pain. 8 to 10 - severe pain.
Time frame: 1st day, 3rd day and 1 week
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hams Hamed Abdelrahman